Non-dihydropyridine calcium channel blocker

This page covers all Non-dihydropyridine calcium channel blocker drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting L-type voltage-gated calcium channel, L-type calcium channel.

Targets

L-type voltage-gated calcium channel · L-type calcium channel

Marketed (2)

• Diltiazem Injectable Product · Virginia Commonwealth University · Cardiovascular
  Diltiazem is a non-dihydropyridine calcium channel blocker that inhibits calcium influx into cardiac and vascular smooth muscle cells, reducing heart rate and blood pressure.
• Diltiazem treated group · Seoul National University Hospital · Cardiovascular
  Diltiazem blocks L-type calcium channels in cardiac and vascular smooth muscle, reducing calcium influx and decreasing heart rate and blood pressure.

Phase 3 pipeline (1)

• Intravenous Diltiazem · Oman Medical Speciality Board · Cardiovascular
  Diltiazem is a non-dihydropyridine calcium channel blocker that inhibits calcium influx into cardiac and vascular smooth muscle cells, reducing heart rate and blood pressure.

Patent intelligence

• non dihydropyridine calcium channel blocker patent landscape — aggregated cliff calendar, attackable patents, originator estates